Your browser doesn't support javascript.
loading
Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial.
McCurdy, Sandra; Keedy, Kara; Lawrence, Laura; Nenninger, Ashley; Sheets, Amanda; Quintas, Megan; Cammarata, Sue.
Afiliación
  • McCurdy S; Melinta Therapeutics, Morristown, New Jersey, USA smccurdy@melinta.com.
  • Keedy K; Melinta Therapeutics, Morristown, New Jersey, USA.
  • Lawrence L; Melinta Therapeutics, Morristown, New Jersey, USA.
  • Nenninger A; Melinta Therapeutics, Morristown, New Jersey, USA.
  • Sheets A; Melinta Therapeutics, Morristown, New Jersey, USA.
  • Quintas M; Melinta Therapeutics, Morristown, New Jersey, USA.
  • Cammarata S; Melinta Therapeutics, Morristown, New Jersey, USA.
Antimicrob Agents Chemother ; 64(3)2020 02 21.
Article en En | MEDLINE | ID: mdl-31844013
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antibacterianos Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antibacterianos Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos